Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies
Thrombotic and bleeding risks, as well as the incidence and presentation of cardiovascular events and related outcomes, appear to differ between genders, partly in relation to variability in age, comorbidities and body size.Women experience frequent fluctuations of pro-thrombotic activity during their lifetime, related to menstrual cycles, the use of oral contraceptives, pregnancy, menopause, and hormone replacement therapy, all with potential impact on the clinical manifestations of atherosclerotic disease.
Source: International Journal of Cardiology - Category: Cardiology Authors: Giulia Renda, Giuseppe Patti, Irene Marthe Lang, Jolanta M. Siller-Matula, Elaine M. Hylek, Giuseppe Ambrosio, Sylvia Haas, Raffaele De Caterina, Working Group on Thrombosis of the Italian Society of Cardiology Tags: Review Source Type: research
More News: Bleeding | Cardiology | Cardiovascular | Heart | Hormone Replacement Therapy | Hormones | Italy Health | Men | Menopause | Pregnancy | Thrombosis | Women